Polyhedral Oligomeric Silsesquioxane Based Material for Tumor Heterogeneity MR Visualization and Precise Treatment
SusMat · 2026-04 · 6 (2)
DOI: 10.1002/sus2.70061 ↗Kurz gefasst
Fachartikel in der Zeitschrift SusMat, online erschienen am 14.03.2026. Verfasst von Xiaochuan Geng und 13 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
Malignant tumors whose mortality rates up to 97% possess high heterogeneity that leads to rapid growth, strong invasive capability, and low drug sensitivity. Quantitative magnetic resonance imaging enables direct visualization of tumors. However, gadolinium‐based contrast agents used in clinical practice have significant drawbacks of short half‐life, non‐specificity, and toxicity after gadolinium ions leakage. Herein, this study constructs a nanomaterial termed FFDP that utilizes octa (3‐mercaptopropyl) silsesquioxane (POSS‐SH) as functional bridge where the double‐bonded folate, double‐bonded doxorubicin, iron (II, III) oxide, and black phosphorus are grafted by chemical and metallic bonds through “click chemistry” approach. The FFDP being administered intravenously, enables real‐time targeted enrichment of MR contrast that corresponding to the tumor heterogeneity and allow for precise tumor treatment at the site of in‐situ triple‐negative breast cancer (TNBC). Moreover, FFDP can deliver the anti‐tumor drug into the deep tumor tissue. In an animal model of in‐situ TNBC, efficient tumor ablation can be performed under FFDP enhanced quantitative magnetic resonance imaging. In conclusion, the FFDP nanomaterial designed in this study achieves real‐time spatial tumor heterogeneity observation and precision tumor treatment. In clinical practice, POSS‐based nanomaterials possess immense potential for MRI‐guided individualized precision treatment for tumors.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Geng, X., Zhuang, Z., Zhang, J., Zhao, X., Lyu, H., Fu, Z., Liu, X., Qian, T., Li, Z., Chen, T., Zhang, Q., Zhou, Y., Lu, Y., & Wei, G. (2026). Polyhedral Oligomeric Silsesquioxane Based Material for Tumor Heterogeneity MR Visualization and Precise Treatment. SusMat, 6(2). https://doi.org/10.1002/sus2.70061
Vancouver
Geng X, Zhuang Z, Zhang J, Zhao X, Lyu H, Fu Z, et al. Polyhedral Oligomeric Silsesquioxane Based Material for Tumor Heterogeneity MR Visualization and Precise Treatment. SusMat. 2026;6(2). doi:10.1002/sus2.70061
BibTeX
@article{Geng2026,
author = {Geng, Xiaochuan and Zhuang, Zhiguo and Zhang, Jiahui and Zhao, Xinxin and Lyu, Haiying and Fu, Zi and Liu, Xi and Qian, Ting and Li, Zhihui and Chen, Tongtong and Zhang, Qing and Zhou, Yan and Lu, Yong and Wei, Gang},
title = {Polyhedral Oligomeric Silsesquioxane Based Material for Tumor Heterogeneity MR Visualization and Precise Treatment},
journal = {SusMat},
year = {2026},
volume = {6},
number = {2},
doi = {10.1002/sus2.70061}
}
EUVIMED